This compound was also examined for mu-opioid receptor action, and like conolidine, was located to have no activity at the site. Utilizing the same paw injection test, a number of alternatives with higher efficacy had been observed that inhibited the First pain response, indicating opiate-like exercise. Given the different mechanisms of such conoli